Skip to main content

Table 1 Pre-treatment characteristics for the study population

From: Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study

Pre-treatment characteristics All (n = 207)a Venlafaxine (n = 98)a Sertraline (n = 109)a
N(%)
Demographic information
Male gender 124 (60.2) 61 (62.2) 63 (58.3)
Country of origin
 Ex-Yugoslavia 20 (9.7) 11 (11.2) 9 (8.3)
 Iran 28 (13.6) 13 (13.3) 15 (13.9)
 Iraq 71 (34.5) 34 (34.7) 37 (34.3)
 Afghanistan 28 (13.6) 10 (10.2) 18 (16.7)
 Lebanon 26 (12.6) 12 (12.2) 14 (13.0)
 Other 33 (16.2) 18 (18.4) 15 (13.9)
Diagnosis (ICD-10) in addition to PTSD
 Depression 204 (98.6) 96 (97.96) 108 (99.08)
 Enduring personality change after catastrophic experience (F.62.0) 80 (40.8) 38 (41.30) 42 (40.38)
 Other psychiatric disorder 24 (11.7) 12 (12.24) 12 (11.11)
Trauma history
 Imprisonment 110 (53.4) 57 (58.8) 53 (48.6)
 Torture** 99 (48.1) 54 (55.1) 45 (41.7)
 Refugee camp 52 (25.7) 22 (22.9) 30 (27.5)
Psychosocial status
 Education >10 years from home country 98 (50.8) 50 (53.2) 48 (48.5)
 Presently employed/studying 14 (7.0) 7 (7.3) 7 (6.8)
 Living alone all the time 51 (25.8) 21 (21.9) 30 (29.4)
 Have got children less than 18 years old 137 (68.8) 68 (70.8) 69 (67.0)
Mean(SD)
 Age 43.7 (9.7) 43.2 (9.6) 44.0 (9.7)
 Years since arrival in Denmark 14.6 (7.3) 14.1 (7.1) 15.1 (7.4)
  1. Pre-treatment characteristics for the venlafaxine and sertraline groups
  2. N Number of study participants, SD Standard deviation
  3. ** Group difference borderline significant, p = 0.054
  4. aNot all variables available for the entire patient group